These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 171186

  • 1. In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptor.
    Capony F, Rochefort H.
    Mol Cell Endocrinol; 1975 Sep; 3(3):233-51. PubMed ID: 171186
    [Abstract] [Full Text] [Related]

  • 2. Antiestrogen action in the uterus: biological ineffectiveness of nuclear bound estradiol after antiestrogen.
    Katzenellenbogen BS, Ferguson ER.
    Endocrinology; 1975 Jul; 97(1):1-12. PubMed ID: 166821
    [Abstract] [Full Text] [Related]

  • 3. Binding of [3-H]estradiol by brain cell nuclei and female rat sexual behavior: inhibition by antiestrogens.
    Roy EJ, Wade GN.
    Brain Res; 1977 Apr 22; 126(1):73-87. PubMed ID: 856418
    [Abstract] [Full Text] [Related]

  • 4. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS, Baudendistel LJ.
    Endocrinology; 1977 Feb 22; 100(2):420-6. PubMed ID: 832632
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of antiestrogen action: temporal patterns of antagonism of estrogen stimulated uterine growth and effects on estrogen receptor levels.
    Ferguson ER, Katzenellenbogen BS.
    Endocrinology; 1977 May 22; 100(5):1242-51. PubMed ID: 849721
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth.
    Clark JH, Anderson JN, Peck EJ.
    Steroids; 1973 Nov 22; 22(5):707-18. PubMed ID: 4357534
    [No Abstract] [Full Text] [Related]

  • 7. Control of uterine estrogen receptor levels by progesterone.
    Hsueh AJ, Peck EJ, Clark JH.
    Endocrinology; 1976 Feb 22; 98(2):438-44. PubMed ID: 174899
    [Abstract] [Full Text] [Related]

  • 8. Effect of nafoxidine (U-11,100A) on the induction of uterine peroxidase.
    McNabb T, Jellinck PH.
    Steroids; 1976 May 22; 27(5):681-9. PubMed ID: 181872
    [Abstract] [Full Text] [Related]

  • 9. Comparison between the action of estradiol and that of the antiestrogen U 11-100 A on the induction in the rat uterus of a specific protein (the induced protein).
    Mairesse N, Galand P.
    Endocrinology; 1979 Nov 22; 105(5):1248-53. PubMed ID: 488011
    [Abstract] [Full Text] [Related]

  • 10. (3H)-estradiol binding by chick liver nuclear extracts: mechanism of increase in binding following estradiol injection.
    Lazier C.
    Steroids; 1975 Sep 22; 26(3):281-98. PubMed ID: 173044
    [Abstract] [Full Text] [Related]

  • 11. The effect of antiestrogens on the nuclear binding of the estrogen receptor.
    Ruh TS, Ruh MF.
    Steroids; 1974 Aug 22; 24(2):209-24. PubMed ID: 4370897
    [No Abstract] [Full Text] [Related]

  • 12. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ, Nelson K, van Nagell JR, Donaldson ES, Walden ML, Gallion H, Kenady DE.
    Endocrinology; 1987 Apr 22; 120(4):1608-14. PubMed ID: 3830064
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM, Williams M, Upchurch S, Clark JH.
    Endocrinology; 1981 Jul 22; 109(1):62-9. PubMed ID: 7238414
    [Abstract] [Full Text] [Related]

  • 14. Effect of ionic strength on charcoal adsorption assays of receptor-estradiol complexes.
    Peck EJ, Clark JH.
    Endocrinology; 1977 Oct 22; 101(4):1034-43. PubMed ID: 908263
    [Abstract] [Full Text] [Related]

  • 15. Androgen-uterine interaction: nuclear translocation of the estrogen receptor and induction of the synthesis of the uterine-induced protein (IP) by high concentrations of androgens in vitro but not in vivo.
    Schmidt WN, Sadler MA, Katzenellenbogen BS.
    Endocrinology; 1976 Mar 22; 98(3):702-16. PubMed ID: 177269
    [Abstract] [Full Text] [Related]

  • 16. Effects of nafoxidine on the luteinizing hormone surge: temporal distribution of estrogen receptors and induction of cytoplasmic progestin receptors in the hypothalamus-preoptic area, pituitary, and uterus of the immature rat.
    Attardi B, Palumbo LA.
    Endocrinology; 1981 Nov 22; 109(5):1365-74. PubMed ID: 7297482
    [Abstract] [Full Text] [Related]

  • 17. The molecular mechanism of the in vitro 4 S to 5 S transformation of the uterine estrogen receptor.
    Notides AC, Nielsen S.
    J Biol Chem; 1974 Mar 25; 249(6):1866-73. PubMed ID: 4361828
    [No Abstract] [Full Text] [Related]

  • 18. Estradiol dependent decrease of binding inhibition by anti-estrogens (a possible test of receptor activation).
    Rochefort H, Capony F.
    Biochem Biophys Res Commun; 1977 Mar 21; 75(2):277-85. PubMed ID: 557979
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of the anti-oestrogen, nafoxidine hydrochloride, with the soluble nuclear oestradiol-binding protein in chick liver.
    Lazier CB, Alford WS.
    Biochem J; 1977 Jun 15; 164(3):659-67. PubMed ID: 883957
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo interactions of [3H]dimethylstilbestrol with the estrogen receptor.
    Capony F, Rochefort H.
    Mol Cell Endocrinol; 1977 Jul 15; 8(1):47-64. PubMed ID: 560324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.